This is a working overview of CAS Registry Number, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-24. Anything still debated is marked as such rather than presented as settled.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
| Property | Value | Notes |
|---|---|---|
| Primary proposed target | HGF/c-Met signaling | Direct binding not confirmed |
| Research models | Rodent and cell studies | Preclinical only |
| Human clinical data | None published | Safety and efficacy unknown |
| Regulatory status | Unapproved research chemical | Status varies by country |
| Typical research purity | 95% or higher by HPLC | Depends on supplier and batch |
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
semiconservative replication The standard mode of DNA replication that occurs in all living cells, in which each of the two parental strands of the original double-stranded DNA molecule are used as template strands, with DNA polymerases replicating each strand separately and simultaneously in antiparallel directions. The result is that each of the two double-stranded daughter molecules is composed of one of the original parental strands and one newly synthesized complementary strand, such that each daughter molecule conserves the precise sequence of information (indeed the very same atoms) from one-half of the original molecule. Contrast conservative replication and dispersive replication.
== Medical uses == In July 2021, azvudine became conditionally approved in China for the following indication: "to treat high-viral-load cases of HIV-1, in combination with a nucleoside reverse-transcriptase inhibitor and a non-nucleoside reverse-transcriptase inhibitor". The approval text describes it as a dual reverse transcriptase and Vif inhibitor. In July 2022, azvudine received emergency conditional approval for COVID-19 in adults. It is believed to work by inhibiting the RNA-dependent RNA polymerase (RdRp) enzyme in the SARS-CoV-2 virus.
=== 17 June === Ukraine launched a drone attack on western Russia, with the HUR claiming to have struck a metallurgical plant and military production facilities in Belgorod, Voronezh, and Lipetsk Oblasts. The Russian Investigative Committee charged Ukrainian Colonel Mykola Dzyaman with terrorism in absentia and placed him on a wanted list for ordering the shooting down of a A-50U over the Sea of Azov on 23 February 2024.
== History == In 1994 Tsutomu Nomizu and colleagues at Nagoya University performed the first mass spectrometry experiments of single cells. Nomizu realized that single cells could be nebulized, dried, and ignited in plasma to generate clouds of ions which could be detected by emission spectrometry. In this type of experiment elements such as calcium within the cell could be quantified. Inspired by Flow cytometry, in 2007 Scott D. Tanner built upon this ICP-MS with the first multiplexed assay using lanthanide metals to label DNA and cell surface markers. In 2008 Tanner described the tandem attachment of a flow cytometer to an ICP-MS instrument as well as new antibody tags that would allow massively multiplexed analysis of cell markers. By further optimizing the detection speed and sensitivity of this flow coupled to ICP-MS they built the first CyTOF instrument. The CyTOF instrument was originally owned by the Canadian company DVS Sciences but is now the exclusive product of Fluidigm after their acquisition in 2014 of DVS sciences. In 2022 Fluidigm received a capital infusion and changed its name to Standard BioTools. There have been 4 iterations of the CyTOF apparatus named CyTOF, CyTOF2, Helios™ and CyTOF XT. The successive improvements were largely in increased detection range and software parameters with the Helios instrument able to detect from metals ranging from yttrium-89 to bismuth-209 and throughput and analyze 2000 events per minute.
In July 2018, Michael Collins, deputy assistant director of the CIA's East Asia mission center, told the Aspen Security Forum in Colorado that he believed China under General Secretary of the Chinese Communist Party Xi Jinping, while unwilling to go to war, was waging a "quiet kind of cold war" against the United States, seeking to replace the US as the leading global power. He further elaborated: "What they're waging against us is fundamentally a cold war — a cold war not like we saw during [the] Cold War (between the U.S. and the Soviet Union) but a cold war by definition". In October 2018, Hong Kong's Lingnan University professor Zhang Baohui told The New York Times that a speech by United States Vice-president Mike Pence at the Hudson Institute "will look like the declaration of a new Cold War". In January 2019, Robert D. Kaplan of the Center for a New American Security wrote that "it is nothing less than a new cold war: The constant, interminable Chinese computer hacks of American warships' maintenance records, Pentagon personnel records, and so forth constitute war by other means. This situation will last decades and will only get worse". In February 2019, Joshua Shifrinson, an associate professor from Boston University, said concerns over a new cold war was "overblown", saying US–China relations were different from that of US–Soviet Union relations during the original Cold War, and that ideology would play a less prominent role in their bilateral relationship.
Sources: en.wikipedia.org
=== Joel Graham === Joel Graham (Sam Jaeger) is Julia's husband and Sydney and Victor's father. He is a stay-at-home father, and is popular among the stay-at-home mothers in their social circle at Sydney's school, a fact which sometimes puts strains on his marriage. He is shown to be very capable domestically and hosts a regular playdate that is very popular. Though he's 100% committed to the job of raising his daughter, he sometimes finds himself starved for adult interaction. He is a licensed contractor and he and Julia agreed that he would stay home with Sydney after he couldn't afford to keep paying his crew. In season two, it is revealed that his mother died when he was younger, something that affects his faith and belief in an afterlife. In the season finale of season 3, Julia and Joel adopt a young boy named Victor. In season 4, Julia becomes a stay-at-home mom while Joel returns to work as a contractor. In season 5, Joel moves into his own apartment because he can't cope with her emotional affair with Ed, a parent Julia volunteers with at the school, which leads to him kissing her. It is also revealed during their separation that his father cheated on his mother, which may be the reason why Julia's behavior is affecting him so much. In the final season, Joel and Julia are able to mend their broken relationship and adopt Victor baby sister. Soon after, it is revealed that Julia has given birth to a son.
=== Factors other than glucose that affect A1c === Lower-than-expected levels of HbA1c can be seen in people with shortened red blood cell lifespans, such as with glucose-6-phosphate dehydrogenase deficiency, sickle-cell disease, or any other condition causing premature red blood cell death. Other variant hemoglobins, such as HbF or HbE, may have different glycation characteristics or respond differently in a HbA1c test. For these patients, alternate assessment with fructosamine or glycated albumin is recommended; these methods reflect glycemic control over the preceding 2–3 weeks. In a blood donor, donation will result in loss of mature RBCs and their rapid replacement with newly formed red blood cells. Since these new RBCs will have only existed for a short period of time, their presence will lead HbA1c to underestimate the actual average levels. There may also be distortions resulting from blood donation during the preceding two months, due to an abnormal synchronization of the age of the RBCs, resulting in an older than normal average blood cell life (resulting in an overestimate of actual average blood glucose levels). Conversely, higher-than-expected levels can be seen in people with a longer red blood cell lifespan, such as with iron deficiency. Results can be unreliable in many circumstances, for example after blood loss, after surgery, blood transfusions, anemia, or high erythrocyte turnover; in the presence of chronic renal or liver disease; after administration of high-dose vitamin C; or erythropoetin treatment. Hypothyroidism can artificially raise the A1c.
=== Peak width definition === In the peak width definition, the value of ΔM is the width of the peak measured at a specified fraction of the peak height, for example 0.5%, 5%, 10% or 50%. The latter is called the full width at half maximum (FWHM).
In an absorption refrigeration system, thermal energy is used to drive a refrigerant through an absorber–generator solution circuit rather than relying primarily on a mechanical compressor. Absorption refrigeration has a long history: an ammonia–water machine was introduced by Ferdinand Carré in 1859, and lithium bromide–water systems were introduced for industrial applications in the 1950s. The refrigerant evaporates at low pressure and is absorbed into a liquid absorbent. The resulting solution is pumped to a higher pressure and heated in a generator, which separates refrigerant vapour from the solution. The refrigerant then condenses, expands and returns to the evaporator, while the absorbent solution returns to the absorber. Two important working-fluid pairs are ammonia–water, in which ammonia is the refrigerant and water is the absorbent, and water–lithium bromide, in which water is the refrigerant and lithium bromide is the absorbent. The choice of working pair affects operating pressure, temperature range and system performance. Because absorption systems can be driven by thermal energy, they can use sources such as industrial waste heat that might otherwise be rejected to the environment. Their performance and suitability relative to vapor-compression refrigeration depend on the working pair, cycle configuration, heat-source temperature and operating conditions.
Bank served with various Office of Strategic Services (OSS) units, including Jedburgh teams advising and leading French Resistance units before the Battle of Normandy ("D-Day" invasion) of 6 June 1944. LTC Martin was a mustang, having enlisted at age 17; he was promoted to second lieutenant during WWII. Before being commissioned he was the US VIIth Army's Boxing Champion for his weight class. He served as a company commander with the 82 Airborne and saw action in North Africa, Sicily, Market Garden, and the Battle of the Bulge. He received his third combat jump star in Korea while serving with the 187th Regimental Combat Team. He retired as an LTC at age 37 while serving in Bad Tölz with the 10th Special Forces Group. The 10th SFG deployed to Bad Tölz, Germany the following September. The remaining cadre at Fort Bragg, North Carolina formed the 77th Special Forces Group, which in May 1960 became 7th Special Forces Group. The Special Forces branch was established as a basic branch of the United States Army on 9 April 1987, by Army General Order No. 35.
Sources: en.wikipedia.org
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.
No published human clinical trials are available for dihexa. Its safety and effectiveness in people are therefore unknown. Most available evidence comes from animal and cell studies.
Preclinical studies often measure dendritic spine density and synaptic protein levels. Behavioral tests include maze learning and avoidance tasks. These endpoints are indirect and do not establish clinical benefit.
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.